| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Revenue | $5.38B | +8.0% |
| Cost of Revenue | $2.04B | +10.4% |
| R&D Expense | $1.01B | +9.6% |
| SG&A Expense | $1.47B | +5.7% |
| Operating Income | $876.0M | +5.2% |
| Interest Expense | $96.0M | +14.3% |
| Pre-tax Income | $1.08B | +25.1% |
| Income Tax | $213.0M | -15.1% |
| Net Income | $850.0M |
| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.87B | +4.3% |
| Accounts Receivable | $939.0M | +9.6% |
| Inventory | $1.05B | +2.7% |
| Current Assets | $4.35B | +2.1% |
| Total Assets | $11.30B | +21.9% |
| Current Liabilities | $1.85B | +29.6% |
| Long-term Debt | $2.53B | +41.6% |
| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.41B | +33.9% |
| Capital Expenditures | $128.0M | -16.9% |
| Investing Cash Flow | -$1.73B | -110.9% |
| Financing Cash Flow | $385.0M | +142.2% |
| Free Cash Flow | $1.28B | +42.7% |
| +38.4% |
| EPS (Basic) | $4.93 | +39.7% |
| EPS (Diluted) | $4.91 | +39.9% |
| Total Liabilities |
| $5.42B |
| +30.2% |
| Stockholders' Equity | $5.88B | +15.2% |